Asenapine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Two randomized, double-blind, 26-week core studies (Eastern [EH] and Western Hemisphere [WH]) tested the hypothesis that… (More)
Is this relevant?
2010
2010
INTRODUCTION We conducted a double-blind 1-year trial of asenapine in patients with schizophrenia or schizoaffective disorder… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Asenapine is indicated in adults for acute treatment of manic or mixed episodes associated with bipolar I disorder… (More)
Is this relevant?
2010
2010
Asenapine is approved by the Food and Drugs Administration in adults for acute treatment of schizophrenia or of manic or mixed… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
BACKGROUND Asenapine is approved in the United States for acute treatment of manic or mixed episodes of bipolar I disorder with… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Asenapine is a novel psychopharmacologic agent under development for the treatment of schizophrenia and bipolar disorder. We… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE Asenapine is approved for bipolar disorder and schizophrenia. This was a 3-week, randomized, double-blind, placebo… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
2009
2009
OBJECTIVE To assess the efficacy and tolerability of asenapine versus olanzapine in the extended treatment of bipolar mania… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2008
2008
Atypical antipsychotic drugs, which are more potent direct acting antagonists of brain serotonin (5-HT)2A than dopamine (DA) D2… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE This 6-week trial assessed the efficacy, tolerability, and safety of the investigational psychopharmacologic agent… (More)
Is this relevant?